Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4651
Huazhu Hotels Group
HTHT
$12.9B
| $2.63M | ﹤0.01% |
66,594
-291,853
| -81% | -$12.3M |
|
4652
PUT
Black Stone Minerals
BSM
$3.05B
| $2.62M | ﹤0.01% |
152,300
+2,500
| +2% | +$42.6K |
|
4653
America's Car Mart
CRMT
$25.7M
| $2.62M | ﹤0.01% |
28,814
+28,740
| +38,838% | +$3M |
|
|
GES
4654
CALL
DELISTED
Guess Inc
GES
| $2.62M | ﹤0.01% |
121,100
-70,800
| -37% | -$1.5M |
|
4655
PUT
Amylyx Pharmaceuticals
AMLX
$2.41B
| $2.62M | ﹤0.01% |
143,100
-23,100
| -14% | -$488K |
|
|
BPMC
4656
PUT
DELISTED
Blueprint Medicines
BPMC
| $2.61M | ﹤0.01% |
52,000
+10,300
| +25% | +$550K |
|
|
CSGS
4657
DELISTED
CSG Systems International
CSGS
| $2.61M | ﹤0.01% |
51,070
-79,137
| -61% | -$4.21M |
|
4658
Broadridge
BR
$19.5B
| $2.61M | ﹤0.01% |
14,565
-7,626
| -34% | -$1.35M |
|
4659
CALL
Transmedics
TMDX
$3.07B
| $2.61M | ﹤0.01% |
47,600
+25,500
| +115% | +$1.84M |
|
4660
PUT
Fox Class A
FOXA
$29B
| $2.61M | ﹤0.01% |
83,500
-13,700
| -14% | -$450K |
|
|
NEWR
4661
PUT
DELISTED
New Relic, Inc.
NEWR
| $2.6M | ﹤0.01% |
30,400
-1,000
| -3% | -$80.6K |
|
4662
CALL
Principal Financial Group
PFG
$24.4B
| $2.6M | ﹤0.01% |
36,100
-32,100
| -47% | -$2.49M |
|
|
AVTA
4663
DELISTED
Avantax, Inc. Common Stock
AVTA
| $2.6M | ﹤0.01% |
101,666
+97,590
| +2,394% | +$2.31M |
|
4664
ADC Therapeutics
ADCT
$129M
| $2.6M | ﹤0.01% |
2,898,121
-271,728
| -9% | -$361K |
|
4665
iShares Micro-Cap ETF
IWC
$1.52B
| $2.6M | ﹤0.01% |
25,955
+10,869
| +72% | +$1.18M |
|
4666
CALL
Agilon Health
AGL
$1.63B
| $2.6M | ﹤0.01% |
5,848
+460
| +9% | +$208K |
|
4667
Calvert International Responsible Index ETF
CVIE
$483M
| $2.6M | ﹤0.01% |
53,691
+28,018
| +109% | +$1.42M |
|
|
CBAY
4668
PUT
DELISTED
Cymabay Therapeutics
CBAY
| $2.59M | ﹤0.01% |
174,000
+169,400
| +3,683% | +$2.25M |
|
4669
CALL
NNN REIT
NNN
$8.83B
| $2.59M | ﹤0.01% |
73,400
+48,200
| +191% | +$1.93M |
|
4670
Under Armour Class C
UA
$2.26B
| $2.59M | ﹤0.01% |
406,469
-498,901
| -55% | -$3.44M |
|
4671
E.W. Scripps
SSP
$320M
| $2.59M | ﹤0.01% |
473,095
+200,197
| +73% | +$1.66M |
|
4672
First Majestic Silver
AG
$9.49B
| $2.59M | ﹤0.01% |
504,850
-163,363
| -24% | -$971K |
|
4673
Riskified
RSKD
$875M
| $2.59M | ﹤0.01% |
578,058
-98,406
| -15% | -$453K |
|
|
CIVI
4674
CALL
DELISTED
Civitas Resources
CIVI
| $2.59M | ﹤0.01% |
32,000
-8,800
| -22% | -$681K |
|
4675
The Greenbrier Companies
GBX
$1.41B
| $2.59M | ﹤0.01% |
64,681
-141,824
| -69% | -$6.09M |
|
Similar funds
Citadel Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Citadel Advisors held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citadel Advisors's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citadel Advisors's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Citadel Advisors added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Citadel Advisors's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Citadel Advisors fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Citadel Advisors's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Citadel Advisors opened 1,406 new positions and closed 1,460 in Q3 2023.
- Citadel Advisors's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.